DEEPSEAPHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 32561365
Skanderborgvej 152 A, Haldum 8382 Hinnerup
info@deepseapharma.dk
tel: 86988840
deepseapharma.dk
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 789.80 | 2 156.96 | 3 093.90 | 2 588.68 | 4 435.38 |
| Employee benefit expenses | - 765.28 | - 945.50 | - 794.62 | - 944.28 | - 824.95 |
| Other operating expenses | -33.70 | ||||
| Total depreciation | -24.96 | -14.60 | - 803.60 | - 801.50 | - 800.00 |
| EBIT | 965.86 | 1 196.87 | 1 495.68 | 842.90 | 2 810.43 |
| Other financial income | 0.69 | 4.98 | 1.77 | 4.72 | 8.89 |
| Other financial expenses | -27.69 | -32.94 | -57.45 | -71.48 | -27.72 |
| Pre-tax profit | 938.86 | 1 168.90 | 1 439.99 | 776.14 | 2 791.60 |
| Income taxes | - 208.59 | - 257.25 | - 318.67 | - 171.13 | - 615.04 |
| Net earnings | 730.26 | 911.65 | 1 121.32 | 605.01 | 2 176.57 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Goodwill | 49.00 | 1 600.00 | 800.00 | ||
| Intangible assets total | 49.00 | 1 600.00 | 800.00 | ||
| Machinery and equipment | 8.70 | 5.10 | 1.50 | ||
| Tangible assets total | 8.70 | 5.10 | 1.50 | ||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 901.01 | 1 913.26 | 1 898.98 | 1 903.51 | 1 388.07 |
| Advance payments | 161.50 | 316.09 | 111.69 | ||
| Inventories total | 901.01 | 1 913.26 | 2 060.48 | 2 219.60 | 1 499.76 |
| Current trade debtors | 566.36 | 700.53 | 1 104.97 | 797.32 | 975.32 |
| Current amounts owed by group member comp. | 144.16 | 2 215.33 | |||
| Current other receivables | 10.92 | 67.15 | 17.40 | 190.53 | 9.23 |
| Current deferred tax assets | 100.20 | 201.10 | 301.70 | ||
| Short term receivables total | 577.28 | 767.69 | 1 222.57 | 1 333.11 | 3 501.58 |
| Cash and bank deposits | 787.36 | 804.34 | 313.85 | 688.02 | 1 655.36 |
| Cash and cash equivalents | 787.36 | 804.34 | 313.85 | 688.02 | 1 655.36 |
| Balance sheet total (assets) | 2 274.35 | 3 539.39 | 5 198.40 | 5 040.73 | 6 656.70 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 500.00 | 800.00 | 800.00 | 600.00 | 800.00 |
| Retained earnings | - 251.05 | - 320.79 | - 209.14 | 312.18 | 117.19 |
| Profit of the financial year | 730.26 | 911.65 | 1 121.32 | 605.01 | 2 176.57 |
| Shareholders equity total | 1 104.21 | 1 515.86 | 1 837.18 | 1 642.19 | 3 218.76 |
| Provisions | 2.00 | 0.60 | |||
| Non-current liabilities total | |||||
| Advances received | 13.27 | 8.73 | 38.54 | ||
| Current trade creditors | 131.95 | 643.23 | 326.31 | 697.58 | 1 536.66 |
| Current owed to participating | 42.97 | 44.81 | 51.84 | 115.41 | 24.70 |
| Current owed to group member | 406.43 | 641.92 | 1 138.43 | 1 706.69 | |
| Short-term deferred tax liabilities | 223.52 | 258.65 | 419.47 | 272.03 | 715.64 |
| Other non-interest bearing current liabilities | 363.28 | 434.32 | 1 411.91 | 598.10 | 1 122.41 |
| Current liabilities total | 1 168.13 | 2 022.93 | 3 361.22 | 3 398.54 | 3 437.94 |
| Balance sheet total (liabilities) | 2 274.35 | 3 539.39 | 5 198.40 | 5 040.73 | 6 656.70 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.